A role for the TIM‐3/GAL‐9/BAT3 pathway in determining the clinical phenotype of multiple sclerosis
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
T‐cell immunoglobulin and mucin domain 3 (Tim‐3) ligates galectin‐9 (Gal‐9); this process, resulting in the inhibition of T h 1 responses and in the apoptosis of antigen‐specific cells, is hampered by binding of the molecular adaptor human leukocyte antigen B (HLA‐B)‐associated transcript 3 (Bat3) to the intracellular tail of Tim‐3. Apoptosis of myelin basic protein (MBP)‐specific T lymphocytes correlates with reduced rates of disease progression in multiple sclerosis (MS). We extensively analyzed the Tim‐3/Gal‐9/Bat3 pathway in 87 patients with a diagnosis of stable relapsing‐remitting MS (RRMS), primary progressive MS (PPMS), or benign MS (BEMS), as well as in 40 healthy control (HC) subjects. Results showed that MBP‐specific CD4 + Tim‐3 + , CD4 + /Gal‐9 + , and CD4 + /Tim‐3 + /AV + (apoptotic) T lymphocytes were augmented in the BEMS group, whereas CD4 + /Bat3 + and CD8 + /Bat3 + T lymphocytes were increased and CD4 + /Tim‐3 + /AV + T cells were reduced in the PPMS group (>2 fold and P <0.05 in all cases). Blocking the Tim‐3/Gal‐9 interaction with specific mAb reduced T‐lymphocyte apoptosis and augmented production of IFNγ and IL‐17 in the BEMS, RRMS, and HC groups, but not in the PPMS group. The Tim‐3/Gal‐9 interaction favors apoptosis of MBP‐specific T lymphocytes in BEMS; this process is reduced in PPMS by the up‐regulation of Bat3. Therapeutic interventions aimed at silencing Bat3 could be beneficial in MS.—Saresella, M., Piancone, F., Marventano, I., La Rosa, F., Tortorella, P., Caputo, D., Rovaris, M., Clerici, M., A role for the TIM‐3/GAL‐9/BAT3 pathway in determining the clinical phenotype of multiple sclerosis. FASEB J. 28, 5000–5009 (2014). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
Zhu, C., Anderson, A. C., Schubart, A., Xiong, H., Imitola, J., Khoury, S. J., Zheng, X. X., Strom, T. B., & Kuchroo, V. K. (2005) · Nature Immunology · doi:10.1038/ni1271 · Cited by 2,057
Nylander, A., & Hafler, D. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58649 · Cited by 495
Rangachari, M., Zhu, C., Sakuishi, K., Xiao, S., Karman, J., Chen, A., Angin, M., Wakeham, A., Greenfield, E. A., Sobel, R. A., et al. (2012) · Nature Medicine · doi:10.1038/nm.2871 · Cited by 394
Cited by
TIM3 comes of age as an inhibitory receptor
Wolf, Y., Anderson, A. C., & Kuchroo, V. K. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0224-6 · Cited by 959
Tim‐3 and its role in regulating anti‐tumor immunity
Das, M., Zhu, C., & Kuchroo, V. K. (2017) · Immunological Reviews · doi:10.1111/imr.12520 · Cited by 856
Breaking BAG: The Co-Chaperone BAG3 in Health and Disease
Behl, C. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.04.007 · Cited by 261
Soluble immune checkpoints in cancer: production, function and biological significance
Gu, D., Ao, X., Yang, Y., Chen, Z., & Xu, X. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0449-0 · Cited by 261
Zhu, C., Dixon, K. O., Newcomer, K., Gu, G., Xiao, S., Zaghouani, S., Schramm, M. A., Wang, C., Zhang, H., Goto, K., et al. (2021) · Science Advances · doi:10.1126/sciadv.abd2710 · Cited by 40
Metadata
- Authors
- Saresella, M., Piancone, F., Marventano, I., La Rosa, F., Tortorella, P., Caputo, D., Rovaris, M., & Clerici, M.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2014-08-04
- Volume
- 28
- Issue
- 11
- Pages
- 5000-5009
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2089700848
- Cited by
- 39
- References
- 3
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.